Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 10:00 a.m. Pacific time. The conference will be held at the Encore hotel in Las Vegas.
A live webcast of the presentation can be accessed through the investor relations section of the Company's website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company's website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.
Toronto's favourite fitness and wellness hub, Sweat and Tonic, has opened their first wellness and recovery oasis, Tonic Spa, at The Welltm in the west end of downtown Toronto.
Tonic Spa is a place to relax, rejuvenate and indulge in a wide range of...
Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced it has completed IND-enabling studies for its lead candidate, MIIST305. MIIST305 is being developed for two parallel programs, an...
PANTHERx®?Rare, the leader in rare disease pharmacy, patient access, and support services in?the United States, is pleased to announce three new expansions that will facilitate the company's continued growth and enhance its innovative capabilities to...
Data is everywhere, but insight is rare. Insights are hidden deep in the data and require tons of work and time to dig out. Knowledge professionals in clinical trials, medical, strategy, and regulatory affairs are struggling with the rapid growth of...
INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to...
Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week's American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago,...
